US 2003/0143183 A1 · Combined use of a GLP-1 compound and another drug for treating dyslipidemia

Abstract

Methods and uses for treatment of dyslipidemia comprising administration of a GLP-1 compound and another antidyslipidemic drug.

Claims42

Dependent claims

A method for treating dyslipidemia in a patient in need thereof, said method comprising administration to said patient of an effective amount of a glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug.

Dependencies are inferred from the claim text.

Facts

Application

10/328,284Filed 23 Dec 2002

Priority

DK PA 2001 0197029 Dec 2001

Published

31 Jul 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 31/225
Of acyclic acids, e.g. pravastatin: polycarboxylic acids
A61K 31/366
Lactones: having six-membered rings, e.g. delta-lactones
A61K 31/401
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: proline; Derivatives…
A61K 31/785
Synthetic polymeric materials: polymers containing nitrogen

Abstract

Methods and uses for treatment of dyslipidemia comprising administration of a GLP-1 compound and another antidyslipidemic drug.

Claims42

Dependent claims

Dependencies are inferred from the claim text.

Combined use of a GLP-1 compound and another drug for treating dyslipidemia

Life of this patent

Abstract

Claims42

Combined use of a GLP-1 compound and another drug for treating dyslipidemia

Life of this patent

Abstract

Claims42